EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): S$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.17. In 2024 the company made an earnings per share (EPS) of S$0.18 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.17	-2.92%
2024	S$0.18	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.20	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.10	31.21%
2016	S$0.07631	11.46%
2015	S$0.06847	36.27%
2014	S$0.05024	19.77%
2013	S$0.04195	18.05%
2012	S$0.03554	23.9%
2011	S$0.02868	26.9%
2010	S$0.02260	12.37%
2009	S$0.02011	56.6%
2008	S$0.01284	9.18%
2007	S$0.01176	114.48%
2006	S$0.005485	64.83%
2005	S$0.003328	35.55%
2004	S$0.002455	29.73%
2003	S$0.001892	19.86%
2002	S$0.001579	-2.71%
2001	S$0.001623	1.02%
2000	S$0.001606

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions